| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/11/2001 | CN1291092A pharmaceutical Combinations containing tramadol |
| 04/11/2001 | CN1291091A Orally administrable immediate and prolonged-release Galenic form comprising absorption-promoting agent and use of this absorption-promoting agent |
| 04/11/2001 | CN1290552A External-use medicine for curing prostate disease |
| 04/11/2001 | CN1290540A Chinese medicine suppository for refreshment and removing summer leat |
| 04/11/2001 | CN1290539A Chinese medicine suppository for carsickness |
| 04/11/2001 | CN1290538A Chinese medicine suppository for relieving cough |
| 04/11/2001 | CN1290537A Chinese medicine suppository for rhinitis |
| 04/11/2001 | CN1290534A Quick-acting spray composition for proverting cold and its preparing method |
| 04/11/2001 | CN1290533A Medicine powder |
| 04/11/2001 | CN1290530A Aitongning plaster for cancer and its preparing method |
| 04/11/2001 | CN1290527A Skin-care cream |
| 04/11/2001 | CN1290525A Freeze dried zhalaipulong instant oral composition |
| 04/11/2001 | CN1290524A Ion crosslinking process of preparing medicinal slow-releasing chitosan microball |
| 04/11/2001 | CN1290523A Disposable pharmacotherapeutic nasal suppository |
| 04/11/2001 | CN1290481A Tablet |
| 04/11/2001 | CN1064258C Pseudo-ginseng extract soft capsule and preparing technology thereof |
| 04/11/2001 | CN1064256C White paste for curing spinal disease |
| 04/11/2001 | CN1064250C Jieyangting ointment for scabies |
| 04/11/2001 | CN1064240C Analgesic injection and its preparing method |
| 04/11/2001 | CN1064232C Non freeze-drying powder injection of heart disease curing medicine and preparing method |
| 04/11/2001 | CN1064231C White and hollow capsule |
| 04/11/2001 | CN1064212C Fully water dilutable microemulsions |
| 04/10/2001 | US6214986 Antisense modulation of bcl-x expression |
| 04/10/2001 | US6214957 Solubilizers, emulsifiers and dispersants |
| 04/10/2001 | US6214887 For preventing or treating hyperproliferative vascular disease |
| 04/10/2001 | US6214884 Composition comprising ketanserin and L-carnitine or an alkanoyl L-carnitine for the treatment of CRPS |
| 04/10/2001 | US6214864 Formulation of dihydroartemisinin for the control of wide spectrum of malaria |
| 04/10/2001 | US6214848 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action for prophylaxis and treatment of diabetes; depressing diabetic hyperglycemia |
| 04/10/2001 | US6214805 Genes, gene signals, genomes rna strands and respiratory syncytial virus with promoters |
| 04/10/2001 | US6214804 Producing antibodies directed to protein of hiv virus in mice, dna plasmids |
| 04/10/2001 | US6214621 Ionic conjugate which is stable in biological medium; non-liquid cationic hydrophilic nucleus which is crosslinked matrix of poly- or oligosaccharides and a polyanionic oligonucleotide; delivering oligonucleotides to cell |
| 04/10/2001 | US6214614 Cell cycle regulated repressor and DNA element |
| 04/10/2001 | US6214593 Encapsulation of supported animal cells using gas-phase inorganic alkoxides |
| 04/10/2001 | US6214536 Method of detecting lung disease |
| 04/10/2001 | US6214388 Immunoliposomes that optimize internalization into target cells |
| 04/10/2001 | US6214387 Biodegradable polymer matrices for sustained delivery of local anesthetic agents |
| 04/10/2001 | US6214386 Drug delivery; non time-release formulation |
| 04/10/2001 | US6214385 Controlled absorption diltiazem pharmaceutical formulation |
| 04/10/2001 | US6214384 Nanosheres comprising a biocompatible polysaccharide |
| 04/10/2001 | US6214381 Methazolamide composition and method of use |
| 04/10/2001 | US6214380 Subcoated simulated capsule-like medicament |
| 04/10/2001 | US6214379 Useful for adaptation to schedules, cycles and needs of individuals improving compliance with their therapy, reducing amounts required daily to less than conventionally utilized, and minimizing undesired effects; drug delivery |
| 04/10/2001 | US6214378 Useful for therapy of colon cancer, ulcerative colitis, constipation, diarrhea, osteoporosis; capsule does not undergo change in stomach and in small intestine but starts disintegration in large intestine |
| 04/10/2001 | US6214377 Time-release agent for therapy and prophylaxis of pain and illness |
| 04/10/2001 | US6214376 Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture |
| 04/10/2001 | US6214375 Phospholipid formulations |
| 04/10/2001 | US6214370 Preparing dispersion by stir-mixing analgesic into polymer solution; solidifying dispersion of polymer and analgesic in high humidity to produce porous polymer matrix |
| 04/10/2001 | US6214368 Useful as bone substitute material for treatment of bone disorders and injuries |
| 04/10/2001 | US6214360 Pharmaceutical composition |
| 04/10/2001 | US6214350 Contacting comminuted fruit of ligustrum lucidum and/or ligustrum japonicum and mixtures thereof with water to form an aqueous dispersion, separating insoluble material from aqueous solution, acidifying, purifying |
| 04/10/2001 | US6214345 Lysosomal enzyme-cleavable antitumor drug conjugates |
| 04/10/2001 | US6214342 Method for increasing mean survival times of transplants with LFA-1-specific antibodies |
| 04/10/2001 | US6214332 Applying a composition of a polymerizable cyanoacrylate ester, and an antimicrobially effective amount of a complex of iodine molecules with a biocompatible polymer, and polymerizing to join separated skin sections together |
| 04/10/2001 | US6214327 Antibacterial composition |
| 04/10/2001 | US6214318 Comprising mineral oils, vegetable oils, silicone oils or synthetic oils; thickening agents such as waxes to thicken oils to non-flowable state; optionally adjuvants, drugs and emulsifiers and a liquefied propellant; cooling effect |
| 04/10/2001 | US6214300 Apparatus for making microcapsules, encapsulating pharmaceutical compounds in microcapsules, microcapsules, microcapsule encapsulated pharmaceutical compositions and products; drug delivery |
| 04/10/2001 | US6214253 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application |
| 04/10/2001 | US6212791 Method of applying indicia to a fast-dissolving dosage form |
| 04/10/2001 | CA2210749C Anti-inflammatory eye drop |
| 04/10/2001 | CA2180487C Water for medical treatment, production method thereof, and dialysis apparatus using water for medical treatment as dialysis liquid |
| 04/10/2001 | CA2135925C Use of glycerin in moderating transdermal drug delivery |
| 04/10/2001 | CA2064889C Polymeric materials |
| 04/10/2001 | CA2046861C K2p pro stabilisation |
| 04/10/2001 | CA2024275C Tampon for medical or hygienic purposes and method of making the same |
| 04/10/2001 | CA2019410C Liquid polymer composition, and method of use |
| 04/05/2001 | WO2001023377A2 Polymorphic salt |
| 04/05/2001 | WO2001023362A2 Rate-controlled particles |
| 04/05/2001 | WO2001023277A1 Rapid infusion system |
| 04/05/2001 | WO2001023023A1 Method and apparatus for locating the injection point of an implanted medical device |
| 04/05/2001 | WO2001023000A1 Coating preparations soluble in lower digestive tract |
| 04/05/2001 | WO2001022999A1 Dermal or transdermal application system containing an iota carragheenate |
| 04/05/2001 | WO2001022998A1 Stable calcitriol solution for packaging in vials |
| 04/05/2001 | WO2001022993A2 MUCOSAL DTPa VACCINES |
| 04/05/2001 | WO2001022992A2 Influenza vaccine |
| 04/05/2001 | WO2001022989A2 Method to enhance healing of sternum after sternotomy |
| 04/05/2001 | WO2001022975A1 Composition and method for producing lubricating, germicide foam |
| 04/05/2001 | WO2001022973A1 The use of a positively charged carbohydrate polymer for the prevention of infection |
| 04/05/2001 | WO2001022972A2 Immunostimulatory nucleic acids |
| 04/05/2001 | WO2001022970A1 Therapy with 2-5a and interferon |
| 04/05/2001 | WO2001022969A2 Vasopressin agonist formulation and process |
| 04/05/2001 | WO2001022967A1 Compositions having improved stability |
| 04/05/2001 | WO2001022956A2 NOVEL COMBINATION OF LOTEPREDNOL AND β2-ADRENOCEPTOR AGONISTS |
| 04/05/2001 | WO2001022947A2 Preparation containing active ingredients and/or auxiliary agents with a controlled release of these substances and the use and production of the same |
| 04/05/2001 | WO2001022946A2 Method and device for dispensing adhesive laminate segments |
| 04/05/2001 | WO2001022945A1 Vasopressin antagonist formulation and process |
| 04/05/2001 | WO2001022944A1 Oral controlled release formulations |
| 04/05/2001 | WO2001022943A1 A slow release pharmaceutical composition comprising a magnesium oxychloride cement |
| 04/05/2001 | WO2001022942A1 Pharmaceutical carrier formulation |
| 04/05/2001 | WO2001022941A1 Melt granulated composition and modified release dosage form prepared from said composition |
| 04/05/2001 | WO2001022940A1 Sustained release matrix systems for highly soluble drugs |
| 04/05/2001 | WO2001022939A1 Hydrolyzed cellulose granulations of salts of drugs |
| 04/05/2001 | WO2001022938A1 Antiviral compositions |
| 04/05/2001 | WO2001022937A1 Compositions of tocol-soluble therapeutics |
| 04/05/2001 | WO2001022936A1 Topical suspension formulations containing ciprofloxacin and dexamethasone |
| 04/05/2001 | WO2001022935A1 Use of analgesics as digestive and medicines for expectorating and transdermal therapeutic system using the same |
| 04/05/2001 | WO2001022934A2 Delivery of small doses of ingestible treatments |
| 04/05/2001 | WO2001022917A2 Effervescent compositions comprising nimesulide |
| 04/05/2001 | WO2001022907A1 Drug delivery of phase changing formulation |
| 04/05/2001 | WO2001022791A2 Controlled release compositions comprising nimesulide |
| 04/05/2001 | WO2001005397A8 Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having effective composition of the same |